Senior Housing Concentration And Rising Costs Will Shape Future Returns Here

Catalysts

About National Healthcare Properties

National Healthcare Properties focuses on senior housing communities with an emphasis on private pay, higher-acuity care within a SHOP oriented REIT structure.

What are the underlying business or industry changes driving this perspective?

• Although National Healthcare Properties is increasing exposure to senior housing in response to an aging population, the plan to rotate fully out of outpatient medical facilities concentrates revenue in one care setting. This could limit diversification benefits and influence the stability of segment level NOI and overall earnings.
• While demographic trends support demand for assisted living and memory care, the reliance on occupancy gains at underperforming communities that currently sit below 85% and need concessions or leadership changes introduces execution risk. This can affect revenue growth and net margins if units take longer to fill than expected.
• Although the company has expanded its credit facility to US$1.2b and reduced leverage to 4.6x net debt to annualized further adjusted EBITDA, the plan to fund a sizeable acquisition pipeline and preferred redemptions through the revolver and equity units could increase financing costs and equity dilution. This may weigh on future earnings per share.
• While private pay senior housing and RevPOR growth above annual rent escalators support revenue per unit, the business remains exposed to labor and property level operating costs. Any renewed step up in compensation or insurance expenses from current moderated levels could pressure SHOP cash NOI margins and limit incremental earnings.
• Although National Healthcare Properties is targeting year 1 and year 3 yields in the high single digits on recent and planned acquisitions, the need for ongoing capital expenditures on revenue enhancing projects and operator led turnarounds at recently acquired assets can lengthen the path to those yields and affect the timing of cash NOI and FFO contribution.

Assumptions

How have these above catalysts been quantified?

• This narrative explores a more pessimistic perspective on National Healthcare Properties compared to the consensus, based on a Fair Value that aligns with the bearish cohort of analysts.
• The bearish analysts are assuming National Healthcare Properties's revenue will grow by 8.0% annually over the next 3 years.
• The bearish analysts assume that profit margins will increase from -16.7% today to 7.2% in 3 years time.
• The bearish analysts expect earnings to reach $31.1 million (and earnings per share of $0.55) by about August 2029, up from -$57.6 million today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as $45.1 million.
• In order for the above numbers to justify the price target of the more bearish analyst cohort, the company would need to trade at a PE ratio of 58.4x on those 2029 earnings, up from -21.0x today. This future PE is greater than the current PE for the US Health Care REITs industry at 30.2x.
• The bearish analysts expect the number of shares outstanding to grow by 7.0% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 8.31%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

• National Healthcare Properties is rotating heavily into senior housing and away from outpatient medical facilities. Any long-term slowdown in senior housing demand or shift in care models could reduce revenue growth potential and weigh on cash NOI and earnings.
• The company is leaning on occupancy gains at communities that remain below 85% and is using concessions to fill units. If these assets take longer to stabilize or require deeper discounts, that could limit RevPOR growth, restrain margins, and delay improvements in earnings and funds from operations.
• The acquisition strategy depends on achieving a blended year 1 yield of 7.9% and a projected year 3 yield of 9.7%. If operating partners are unable to deliver the planned operational improvements or revenue enhancing projects do not perform as expected, cash NOI and overall earnings could fall short of current assumptions.
• National Healthcare Properties is funding a large acquisition pipeline and preferred share redemptions partly through its expanded US$1.2b credit facility and equity issuance. Any sustained increase in financing costs or higher than expected equity dilution could reduce net margins and earnings per share.
• The business remains exposed to labor, utility, and insurance costs at the property level. While recent commentary points to moderation and some savings, any renewed or structural rise in these expenses over time could pressure SHOP cash NOI margins and slow growth in earnings.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The assumed bearish price target for National Healthcare Properties is $16.0, which represents up to two standard deviations below the consensus price target of $18.57. This valuation is based on what can be assumed as the expectations of National Healthcare Properties's future earnings growth, profit margins and other risk factors from analysts on the more bearish end of the spectrum.
• However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $24.0, and the most bearish reporting a price target of just $16.0.
• In order for you to agree with the more bearish analyst cohort, you'd need to believe that by 2029, revenues will be $433.3 million, earnings will come to $31.1 million, and it would be trading on a PE ratio of 58.4x, assuming you use a discount rate of 8.3%.
• Given the current share price of $16.61, the analyst price target of $16.0 is 3.8% lower. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.